Leidos (LDOS)
(Delayed Data from NYSE)
$158.51 USD
+1.07 (0.68%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $158.54 +0.03 (0.02%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Company Summary
Founded in 1969, Delaware-based Leidos Holdings, Inc. is a global science and technology leader that serves the defense, intelligence, civil and health markets. Its core capabilities include providing solutions in the fields of cybersecurity; data analytics; enterprise IT modernization; operations and logistics; sensors, collection and phenomenology; software development; and systems engineering.
During the first quarter of 2024, Leidos Holdings completed a realignment of its segment and reporting structure. Consequently, the company currently operates through the following four business segments:
National Security and Digital: This business segment offers technology-enabled ...
Company Summary
Founded in 1969, Delaware-based Leidos Holdings, Inc. is a global science and technology leader that serves the defense, intelligence, civil and health markets. Its core capabilities include providing solutions in the fields of cybersecurity; data analytics; enterprise IT modernization; operations and logistics; sensors, collection and phenomenology; software development; and systems engineering.
During the first quarter of 2024, Leidos Holdings completed a realignment of its segment and reporting structure. Consequently, the company currently operates through the following four business segments:
National Security and Digital: This business segment offers technology-enabled services and mission software capabilities in the areas of cyber, logistics, security operations and decision analytics, as well as IT operations and digital transformation programs. In the second quarter of 2024, this division generated revenues of $1,813 million, contributing 43.9% to Leidos’ total revenues.
Health & Civil: This segment provides services and solutions in the areas of public health, care coordination, life and environmental sciences and transportation. Its core capabilities include health information management services, managed health services, systems and infrastructure modernization, and life sciences research and development. The unit recorded revenues of $1,263 million in the second quarter of 2024 that accounted for 30.6% of Leidos’ total revenues.
Commercial & International: This unit’s products include IT modernization, software solutions, mission support and logistics, Command, Control, Computers, Communications, Intelligence, Surveillance and Reconnaissance (C4ISR) technologies and services, cloud services, power grid engineering, energy modernization and security products and services. Revenues from this division totaled $561 million, representing 13.6% of Leidos’ total revenues.
Defense Systems: This unit develops and produces advanced space, aerial, surface, and sub-surface manned and unmanned defense systems. Revenues from this division totaled $495 million in the second quarter of 2024, representing 12% of Leidos’ total revenues.
General Information
Leidos Holdings, Inc
1750 PRESIDENTS STREET
RESTON, VA 20190
Phone: 571-526-6000
Fax: NA
Email: ir@leidos.com
Industry | Aerospace - Defense |
Sector | Aerospace |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 10/29/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 1.95 |
Current Year EPS Consensus Estimate | 8.95 |
Estimated Long-Term EPS Growth Rate | 12.50 |
Exp Earnings Date | 10/29/2024 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 157.44 |
52 Week High | 158.90 |
52 Week Low | 89.22 |
Beta | 0.68 |
20 Day Moving Average | 707,098.38 |
Target Price Consensus | 168.92 |
4 Week | 8.77 |
12 Week | 9.15 |
YTD | 45.46 |
4 Week | 5.94 |
12 Week | 4.49 |
YTD | 24.07 |
Shares Outstanding (millions) | 134.71 |
Market Capitalization (millions) | 21,209.32 |
Short Ratio | NA |
Last Split Date | 9/30/2013 |
Dividend Yield | 0.97% |
Annual Dividend | $1.52 |
Payout Ratio | 0.17 |
Change in Payout Ratio | -0.05 |
Last Dividend Payout / Amount | 6/14/2024 / $0.38 |
Fundamental Ratios
P/E (F1) | 17.58 |
Trailing 12 Months | 17.61 |
PEG Ratio | 1.40 |
vs. Previous Year | 46.11% |
vs. Previous Quarter | 14.85% |
vs. Previous Year | 7.66% |
vs. Previous Quarter | 3.95% |
Price/Book | 4.70 |
Price/Cash Flow | 11.19 |
Price / Sales | 1.32 |
6/30/24 | 28.40 |
3/31/24 | 25.66 |
12/31/23 | 22.92 |
6/30/24 | 9.59 |
3/31/24 | 8.72 |
12/31/23 | 7.80 |
6/30/24 | 1.21 |
3/31/24 | 1.35 |
12/31/23 | 1.34 |
6/30/24 | 1.11 |
3/31/24 | 1.24 |
12/31/23 | 1.24 |
6/30/24 | 7.66 |
3/31/24 | 7.11 |
12/31/23 | 6.52 |
6/30/24 | 2.72 |
3/31/24 | 2.04 |
12/31/23 | 1.29 |
6/30/24 | 4.47 |
3/31/24 | 3.59 |
12/31/23 | 2.61 |
6/30/24 | 33.48 |
3/31/24 | 31.90 |
12/31/23 | 30.97 |
6/30/24 | 42.94 |
3/31/24 | 43.23 |
12/31/23 | 43.44 |
6/30/24 | 0.91 |
3/31/24 | 1.07 |
12/31/23 | 1.10 |
6/30/24 | 47.67 |
3/31/24 | 51.81 |
12/31/23 | 52.28 |